linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Cash Flow  
Nephrocare Health Services Ltd.
 
BSE Code 544647
ISIN Demat INE428V01029
Book Value 90.17
NSE Code NEPHROPLUS
Dividend Yield % 0.00
Market Cap 53476.59
P/E 156.20
EPS 3.41
Face Value 2  
Type
(Rs. in Million)
ParticularsMar 2025Mar 2024Mar 2023
Profit Before Tax874.37331.61-85.91
Adjustment930.40801.84685.63
Changes In working Capital-441.73-330.02-533.24
Cash Flow after changes in Working Capital1363.04803.4366.48
Cash Flow from Operating Activities1353.47722.80112.69
Cash Flow from Investing Activities-1250.73-506.60-782.06
Cash Flow from Financing Activities543.71267.39599.66
Net Cash Inflow / Outflow646.45483.59-69.71
Opening Cash & Cash Equivalents611.51140.60185.51
Cash & Cash Equivalent on Amalgamation / Take over / Merger000
Cash & Cash Equivalent of Subsidiaries under liquidations000
Translation adjustment on reserves / op cash balalces frgn subsidiaries000
Effect of Foreign Exchange Fluctuations0.21-12.6824.80
Closing Cash & Cash Equivalent1258.17611.51140.60
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.